Catabasis Pharma (CATB) Tops Q2 EPS by 4c

August 11, 2016 4:40 PM EDT
Get Alerts CATB Hot Sheet
Trade CATB Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Catabasis Pharma (NASDAQ: CATB) reported Q2 EPS of ($0.61), $0.04 better than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Catabasis Pharma (CATB) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment